NCT01029106终止不适用
Prospective, Non-Randomized, Observational, Multicentre, Study of the TVT Secur in the Surgical Management of Women With Stress Urinary Incontinence
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 125
- 试验地点
- 1
- 主要终点
- The primary endpoints are the cure/improvement rate in the cohort at 12 months.
研究概览
简要总结
This is a prospective, non-randomized, observational, multicentre (5 sites) study in which subjects that have surgically-correctable Stress Urinary Incontinence undergo a TVT SECUR operative procedure.
The study will collect preoperative urologic testing, medical history, and subject quality of life patient questionnaires, Intraoperative procedural data will be collected.
Postoperative complications, urologic, testing, and subject questionnaires will be collected at intervals up to 24 months. The anatomic position of the device will be characterize by transvaginal ultrasound testing.
To determine the rate and/or improvement rate of patients who have received the Gynecare Secur device after 12 months and after 24 months.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •To be considered eligible to participate in this study, subjects must meet the following requirements:
- •Subject has agreed to undergo surgical implantation of the TVT SECUR System
- •Subject has the complaint of SUI for at least 6 months prior to the Preoperative Evaluation Visit.
- •Subject has confirmed SUI resulting from urethral hypermobility on cough stress testing.
- •Subject has at least 4 gm of urine leakage on 1-hour pad testing during the Preoperative Screening Visit.
- •Subject is at least 18 years of age to maximum of 85 years of age
- •Subject is willing and able to give written informed consent prior to any study related procedures.
- •Subject is willing to return for follow-up evaluation and questionnaire completion at 4-6 weeks, and at 3, 6, 12 and 24 month follow-ups.
- •Subject is willing to undergo transvaginal ultrasound evaluation at the 4 weeks and 12 month follow-up visit.
排除标准
- •Subjects will not be eligible for entry into the study if they meet one of the following criteria:
- •Subject is pregnant.
- •Subject has had any previous synthetic sub-urethral sling procedure.
- •Subject has current urinary tract or vaginal infections.
- •Subject has blood coagulation disorders.
- •Subject has a compromised immune system or any other conditions that would compromise healing.
- •Subject has upper urinary tract obstruction.
- •Subject is unwilling to provide written informed consent.
- •Subject is unwilling or unable to return for evaluation at 4-6 weeks, and at 3, 6, 12, and 24 months.
- •Subject has uncontrolled detrusor overactivity.
- •Subject has PVR greater than 100 cc.
- •Subject has Peak Flow Rate less than 10 ml/sec.
- •Subject has urethral diverticulum.
- •Subject has significant pelvic organ prolapse (Grade III/IV) requiring surgical treatment.
- •Subject has had radiation therapy to the pelvic area at any time.
- •Subject has current or active history of pelvic cancer.
- •Subject who in the opinion of the investigator is unable and/or unlikely to comprehend the nature, scope and possible consequences of the study and to follow the study procedures and instructions and complete all study related measurements.
结局指标
主要结局
The primary endpoints are the cure/improvement rate in the cohort at 12 months.
时间窗: 12 months
次要结局
- Distribution of percentage of subjects having a decrease of pad weight as compared to baseline(24 months)
- Decrease in number of pads used within a 24-hour period as compared to baseline(24 months)
- Change in patient questionnaires from baseline(24 months)
- Change in the sling position on transvaginal ultrasound(24 months)
- Cure/improvement rate at 24 months(24 months)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Registry Study in MSI/dMMR Solid TumorsDMMR CancerMSI-HSolid TumorNCT06004713Peking University Cancer Hospital & Institute190
已完成
不适用
R3® Acetabular System in Patients With Degenerative Hip DiseaseOsteoarthritisNCT01407029Smith & Nephew, Inc.158
已完成
4 期
R3 Acetabular Hip system in patients with degenerative joint disease.Degenerative joint disease.Musculoskeletal - Other muscular and skeletal disordersACTRN12608000234314Smith & Nephew70
进行中（未招募）
Unknown
A post-market prospective clinical study of Nagor PERLE™ mammary implantsBreast surgery: augmentation and reconstruction including revision for womenSurgeryISRCTN96851026agor Ltd700
尚未招募
不适用
Biomarkers of Traumatic Brain Injury With Tbit SystemBrain Injuries, TraumaticNCT04107662BioDirection Inc740